Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Biomaterials. 2021 Nov 15;280:121259. doi: 10.1016/j.biomaterials.2021.121259

Figure 6. ApEn-NK treatment inhibits lung metastasis of TNBC in mice without affecting body weight.

Figure 6.

(A) Treatments were started two weeks post intravenous infusion of TNBC cells and repeated weekly for total eight doses. Lung metastasis formation was monitored weekly by whole-body imaging of mice. (B) Whole-body imaging pre-treatments. (C) Whole-body imaging at study endpoint. Luminescence radiance is displayed as photons/second/square centimeter/steradian. (D) Changes in lung metastasis signals derived from traceable TNBC cells over time. (E) Changes in body weight of treated mice over time. Data are presented as mean ± S.D. **: P<0.01; ***: P<0.001 (Student’s t-test, two-tailed). NS: not significant.